Mochida Pharmaceutical Co., Ltd. (TYO:4534)

Mochida Pharmaceutical Revenue

Mochida Pharmaceutical had revenue of 32.65B JPY in the quarter ending September 30, 2026, with 15.14% growth. This brings the company's total for the last twelve months to 126.33B, up 15.85% year-over-year. In the fiscal year ending March 31, 2026, Mochida Pharmaceutical had annual revenue of 116.95B with 11.21% growth. That makes Mochida Pharmaceutical the 8,784th largest company in the world by revenue and 916th in Japan.

• Revenue (ttm): 126.33B
• Revenue Growth: +15.85%
• P/S Ratio: 0.93
• Revenue / Employee: 85.42M
• Employees: 1,479
• Market Cap: 117.84B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Pharmaceutical 109.04B 93.2%
• Healthcare Business 7.91B 6.8%

Fiscal year ended Mar 31, 2026 See the full Mochida Pharmaceutical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	116.95B	11.79B	11.21%
Mar 31, 2025	105.16B	2.27B	2.21%
Mar 31, 2024	102.89B	-376.00M	-0.36%
Mar 31, 2023	103.26B	-6.92B	-6.28%
Mar 31, 2022	110.18B	7.18B	6.98%

Data Source: S&P Global Market Intelligence Last updated: Nov 11, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 15, 2026

Data Sources Report a data error